Synthetic REV-ERB agonists were identified that can alter the circadian pattern of core clock gene expression in rodents, and when administered to mice with diet-induced obesity, obesity was reduced, and metabolic diseases were alleviated [203]. This evidence concerns the gene CLOCK and obesity disorder.